Matthew Roberts, Ph.D., MBA

Matthew Roberts, Ph.D., MBA has a diverse and extensive work experience. Matthew is currently a Scientific Advisory Board Member at R3SET since March 2022. Previously, they served as the Chief Technology Officer at Nalu Bio from September 2020 and remains there currently, where they develop innovative ingredients for cognitive wellness and addiction recovery. Additionally, they have worked as an Operational Advisor at Treasure8 since October 2020.

In their earlier career, Matthew served as an Advisor and Screening Committee member at Nutrition Capital Network since 2006. Matthew was also the Chief Technology Officer at H&H Group from 2020 to 2021 and held the position of Chief Scientific Officer and Senior Vice President of Innovation at ChromaDex from October 2018 to February 2020. Matthew served as the Chief Technical and Quality Officer at Pharmavite from June 2017 to October 2018, and as the Chief Scientific Officer at NBTY, Inc. in 2015.

From 2010 to 2015, Matthew held various leadership roles at Abbott, including Divisional Vice President of Global Product Research & Development and Divisional Vice President of Strategic Research. Matthew'sresponsibilities involved managing product development, innovation strategy, and overseeing technical support for factory operations.

Prior to joining Abbott, Matthew worked at Nestle from 2005 to 2009. Matthew held the positions of Assistant Vice President in the Nestle Strategic Business Unit, where they managed general management, business development, and operational responsibilities for the chocolate business. Matthew also worked as a Financial Advisor, responsible for acquisitions, developing Nestle's venture capital program, and portfolio management for the Nestle Wellness Venture Board.

Throughout their career, Matthew Roberts has demonstrated a strong expertise in scientific research, technology development, innovation strategy, and leadership in the food and nutrition industry.

Matthew Roberts, Ph.D., MBA completed their education in a chronological order. Matthew earned their Bachelor of Science (B.S.) degree in Molecular Biology from Purdue University from 1986 to 1991. Following this, they pursued their Ph.D. in Toxicology at Cornell University, where they studied from 1991 to 1995. To further enhance their knowledge in the field of business administration, they attended Washington University in St. Louis - Olin Business School, completing an Executive MBA program in 2004 to 2005.